Combination of popular antibiotic and cardiac medication increases risk of sudden cardiac death in older patients

FOR VACCINATION: Book an appointment for COVID-19 vaccination. >>

FOR TESTING: Book an appointment for COVID-19 testing at one of our Assessment Centres. >>


Our Stories

Combination of popular antibiotic and cardiac medication increases risk of sudden cardiac death in older patients

Toronto, February 2, 2015

Tens of millions of antibiotic prescriptions are dispensed every year in North America. For older patients who take trimethoprim-sulfamethoxazole, a common antibiotic, and spironolactone, a diuretic widely used for heart failure, the combination can double their risk of sudden cardiac death, new research has found.

Researchers at the Institute for Clinical Evaluative Sciences and St. Michael’s Hospital looked at patients 66 years and older who died while taking spironolactone and one of five commonly prescribed antibiotics.

They found that older patients who received trimethoprim-sulfamethoxazole in combination with spironolactone had more than a two-fold increase in the risk of sudden death compared with amoxicillin, a penicillin antibiotic also used to treat infections.

“Sudden outpatient death from hyperkalemia is often misattributed to heart disease, particularly in older patients,” said Dr. Tony Antoniou, a pharmacist in St. Michael’s Department of Family and Community Medicine, a scientist at ICES and lead author of the study published today in CMAJ.

Both trimethoprim-sulfamethoxazole and spironolactone raise the level of potassium in the blood. Together, they increase the risk of dangerously high blood potassium levels, known as hyperkalemia. Severe hyperkalemia can cause fatigue, muscle weakness and sudden death due to an irregular heart rhythm.

The study identified 11,968 patients between 1994 and 2011 who died suddenly while taking spironolactone. Of those, 328 died within 14 days of antibiotic exposure. Compared with amoxicillin, trimethoprim-sulfamethoxazole was associated with a more than two-fold increase in the risk of sudden death. There was also a less pronounced risk for those taking ciprofloxacin. In contrast, no such risk was found with norfloxacin.

“Physicians should consider using alternate antibiotics in patients with other risk factors for hyperkalemia when clinically appropriate,” added Antoniou.

About St. Michael's Hospital

St. Michael’s Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in 27 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the hospital’s recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

Media contacts

For more information, or to arrange an interview with Dr. Antoniou, please contact:

Leslie Shepherd
Manager, Media Strategy, St. Michael's Hospital

See More of Our Stories in 2015